Zhou L, Xiao B. Emergency contraception with Multiload Cu-375 SL IUD: a multicenter clinical trial. Contraception. 2001;64(2):107–12.
This was resource was additionally used in the development of this module.
Wu S, Godfrey EM, Wojdyla D, Dong J, Cong J, Wang C et al. Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. BJOG. 2010;117(10):1205–10. doi:10.1111/j.1471- 0528.2010.02652.x.
This was resource was additionally used in the development of this module.
von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bartfai G et al.; WHO Research Group on Post-ovulatory Methods of Fertility Regulation. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomis
This was resource was additionally used in the development of this module.
Turok DK, Godfrey EM, Wojdyla D, Dermish A, Torres L, Wu SC. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle. Hum Reprod. 2013;28(10):2672–6. doi:10.1093/ humrep/det330.
This was resource was additionally used in the development of this module.
Trussell J, Rodríguez G, Ellertson C. Updated estimates of the effectiveness of the Yuzpe regimen of emergency contraception. Contraception. 1999;59(3):147–51.
This was resource was additionally used in the development of this module.
Salcedo J, Rodriguez MI, Curtis KM, Kapp N. When can a woman resume or initiate contraception after taking emergency contraceptive pills? A systematic review. Contraception. 2013;87(5):602–4. doi:10.1016/j. contraception.2012.08.013.
This was resource was additionally used in the development of this module.
Roye CF. Routine provisions of emergency contraception to teens and subsequent condom use: a preliminary study [letter]. J Adolesc Health. 2001;28(3):165–6.
This was resource was additionally used in the development of this module.
Rodriguez MI, Godfrey EM, Warden M, Curtis KM. Prevention and management of nausea and vomiting with emergency contraception: a systematic review. Contraception. 2013;87(5):583–9. doi:10.1016/j.contraception.2012.09.031.
This was resource was additionally used in the development of this module.
Rodriguez MI, Gaffield ME. How can a woman take emergency contraceptive pills?
This was resource was additionally used in the development of this module. Document available upon request.
Rodrigues I, Grou F, Joly J. Effectiveness of emergency contraceptive pills between 72 and 120 hours after unprotected sexual intercourse. Am J Obstet Gynecol. 2001;184(4):531–7. doi:10.1067/mob.2001.111102.
This was resource was additionally used in the development of this module.
Raymond EG, Creinin MD, Barnhart KT, Lovvorn AE, Rountree RW, Trussell J. Meclizine for prevention of nausea associated with use of emergency contraceptive pills: a randomized trial. Obstet Gynecol. 2000;95(2):271–7.
This was resource was additionally used in the development of this module.
Raymond E, Taylor D, Trussell J, Steiner MJ. Minimum effectiveness of the levonorgestrel regimen of EC. Contraception. 2004;69(1):79–81.
This was resource was additionally used in the development of this module.
Raine T, Harper C, Leon K, Darney P. Emergency contraception: advance provision in a young, high-risk clinic population. Obstet Gynecol. 2000;96(1):1–7. 7. Recommendations 61.
This was resource was additionally used in the development of this module.
Ragan RE, Rock RW, Buck HW. Metoclopramide pretreatment attenuates emergency contraceptive-associated nausea. Am J Obstet Gynecol. 2003;188(2):330–3.
This was resource was additionally used in the development of this module.
Piaggio G, von Hertzen H. Effect of delay in the administration of levonorgestrel for emergency contraception. Presented at the XVII FIGO World Congress of Gynecology and Obstetrics, 2–7 November 2003, Santiago, Chile.
This was resource was additionally used in the development of this module.
Ngai SW, Fan S, Li S, Cheng L, Ding J, Jing X et al. A randomized trial to compare 24h versus 12h double dose regimen of levonorgestrel for emergency contraception. Hum Reprod. 2005;20(1):307–11.
This was resource was additionally used in the development of this module.
Lovvorn A, Nerquaye-Tetteh J, Glover EK, Amankwah-Poku A, Hays M, Raymond E. Provision of emergency contraceptive pills to spermicide users in Ghana. Contraception. 2000;61(4):287–93.
This was resource was additionally used in the development of this module.
Jackson RA, Bimla Schwartz E, Freedman L, Darney P. Advance supply of emergency contraception: effect on use and usual contraception – a randomized trial. Obstet Gynecol. 2003;102(1):8–16.
This was resource was additionally used in the development of this module.
Ho PC, Kwan MS. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. Hum Reprod. 1993;8(3):389–92.
This was resource was additionally used in the development of this module.
Glasier, AF, Cameron ST, Fine PM, Logan SJ, Casale W, Van Horn J et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet. 2010;375(9714):555–62. doi:10.1016/S0140-6736(
This was resource was additionally used in the development of this module.
Glasier A, Cameron ST, Blithe D, Scherrer B, Mathe H, Levy D et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception. 2011:84(4):363–
This was resource was additionally used in the development of this module.
Glasier A, Baird D. The effects of self-administering emergency contraception. New Engl J Med. 1998;339(1):1–4. doi:10.1056/NEJM199807023390101.
This was resource was additionally used in the development of this module.
Fine P, Mathe H, Ginde S, Cullins V, Morfesis J, Gainer E. Ulipristal acetate taken 48–120 hours after intercourse for emergency contraception. Obstet Gynecol. 2010;115(2 Pt 1):257–63. doi:10.1097/AOG.0b013e3181c8e2aa.
This was resource was additionally used in the development of this module.
Ellertson C, Webb A, Blanchard K, Bigrigg A, Haskell S, Shochet T, Trussell J. Modifying the Yuzpe regimen of emergency contraception: a multicenter randomized controlled trial. Obstet Gynecol. 2003;101(6):1160–7.
This was resource was additionally used in the development of this module.
Ellertson C, Evans M, Ferden S, Leadbetter C, Spears A, Johnstone K et al. Extending the time limit for starting the Yuzpe regimen of emergency contraception to 120 hours. Obstet Gynecol. 2003;101(6):1168–71.
This was resource was additionally used in the development of this module.
Ellertson C, Ambardekar S, Hedley A, Coyaji K, Trussell J, Blanchard K. Emergency contraception: randomized comparison of advance provision and information only. Obstet Gynecol. 2001;98(4):570–5.
This was resource was additionally used in the development of this module.
Dada OA Godfrey EM, Piaggio G, von Hertzen H. A randomized, double blind, noninferiority study to compare two regimens of levonorgestrel for emergency contraception in Nigeria. Contraception. 2010;82(4):373–8. doi:10.1016/j.contraception.2010.06.004.
This was resource was additionally used in the development of this module.
Cleland K, Zhu H, Goldstuck N, Cheng L, Trussell J. The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod. 2012;27(7):1994–2000. doi:10.1093/humrep/des140.
This was resource was additionally used in the development of this module.
Belzer M, Yoshida E, Tejirian T, Tucker D, Chung K, Sanchez K. Advanced supply of emergency contraception for adolescent mothers increased utilization without reducing condom or primary contraception use. J Adolesc Health. 2003;32:122–3.
This was resource was additionally used in the development of this module.
Arowojolu AO, Okewole IA, Adekunle AO. Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians. Contraception. 2002;66(4):269–73.
This was resource was additionally used in the development of this module.
The WHO Medical Eligibility Criteria Wheel for Contraceptive Use (2015)
A tool that makes it easy to identify medical eligibility for use of family planning methods
The Selected Practice Recommendations for Contraceptive Use (3rd Edition 2016)
This resource provides guidance on how to use contraceptive methods safely and effectively, once they are deemed to be medically appropriate.
The Medical Eligibility Criteria for Contraceptive Use (5th edition 2015)
This resource provides guidance on whether people with certain medical conditions can safely and effectively use specific contraceptive methods.
Family Planning: A Global Handbook for Providers (2022 update)
This book serves as a quick-reference resource for all level of health care workers. It provides practical guidance on delivering family planning methods appropriately and effectively.
